Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AKTXthis companyAkari Therapeutics, Plc	$7.54	-0×	0.01×	0×	0.24×	-6.5%	0.0%	0.0%	0.0%	-61.1%	-45.0%	-4345.0%	0.03×	0.26×	-18.2×	0.44×	0.0%	2	-12.64	2	B-
CDTCDT Equity Inc.	$0.97	-0.68×	0.02×	0×	-25.29×	-176008647.0%	0.0%	0.0%	0.0%	-3.1%	-1.3%	-67.4%	1.02×	-24.56×	-115.23×	1.93×	0.0%	7	1.44	3	B
DRMADermata Therapeutics, Inc.	$0.78	-0.28×	0.35×	0×	0.69×	916.2%	0.0%	0.0%	0.0%	-121.5%	-124.9%	-361.0%	0×	0.97×	0×	4.79×	0.0%	1	-23.83	2	C+
REVBRevelation Biosciences, Inc.	$4.17	-0.13×	0.22×	0×	0.88×	2518.1%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-416.3%	0.08×	1.1×	0×	5.41×	0.0%	2	-7.62	2	B-
Peer median	—	-0.28×	0.22×	0×	0.69×	916.2%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-361.0%	0.08×	0.97×	0×	4.79×	0.0%	2	-7.62	2	—